He was an early proponent of antiangiogenesis and is known for the experimental drugs angiostatin and endostatin.

FORBES: Magazine Article

Sure enough, it took years to reproduce those animal findings, and angiostatin and endostatin have been delayed while their backer EntreMed looks for a new partner.

FORBES: On The Cover/Top Stories